- Boehringer Ingelheim (Ridgefield, CT)
- …from Start of Development to Loss of Exclusivity. + Plan and execute non-clinical safety studies and pre-clinical safety assessments at appropriate stages to ... will be the primary interface with global health authorities and will consolidate safety data from nonclinical studies into regulatory submissions as needed. In… more